<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="comprising functionalized nanoparticles (NPs) and quantum dots and nanotechnology-associated innovative" exact="detection" post="methods, vaccine design, and nanodrug production have shown immense"/>
 <result pre="into cells. These viruses have been scrutinized using rapid diagnostic" exact="detection" post="and therapeutic interventional options against the caused infections including"/>
 <result pre="can help resolve the critical issues regarding detection, prevention, and" exact="treatment" post="of viral infections. This perspective review expounds recent nanoscience"/>
 <result pre="infections. This perspective review expounds recent nanoscience advancements for the" exact="detection" post="and treatment of viral infections with focus on coronaviruses"/>
 <result pre="perspective review expounds recent nanoscience advancements for the detection and" exact="treatment" post="of viral infections with focus on coronaviruses and encompasses"/>
 <result pre="portal and the primary site of entry for incursion or" exact="infection" post="by various viruses such as the influenza virus, the"/>
 <result pre="vehicles, including novel nanovaccine transfer platforms and useful nanodrugs for" exact="treatment" post="of viral infection. 2. Nanotechnology against Viral Infections with"/>
 <result pre="attain successful viral replication inhibition; developments of efficient and novel" exact="treatment" post="approaches are thus imperative. For instance, silver NPs with"/>
 <result pre="had a remarkable inhibitory effect against respiratory syncytial virus (RSV)" exact="infection" post="[29]. Nanotechnology-based platforms for nanotherapeutic drugs that are successfully"/>
 <result pre="in Table 1. Additionally, some significant engineered nanomaterials for the" exact="diagnosis" post="and inhibition of CoVs are summarized in Table 2."/>
 <result pre="have attained favorable stature to alter the cycle of viral" exact="infection" post="[60]. The virus entrance into the host cells might"/>
 <result pre="star-shaped bovine serum albumin (BSA)-coated tellurium NPs reportedly suppressed virus" exact="infection" post="predominantly by obstructing the virus internalization procedure; these nanostars"/>
 <result pre="namely the birth of diverse immunoassays and the invention of" exact="polymerase chain reaction" post="(PCR). The first study on the serological detection technique"/>
 <result pre="polymerase chain reaction (PCR). The first study on the serological" exact="detection" post="technique of viruses with different immunoassays was described in"/>
 <result pre="in 1970, in which a radioimmunoassay was utilized towards the" exact="detection" post="of the Australia antigen, which was later labeled, the"/>
 <result pre="were discovered that are still usually employed for the direct" exact="detection" post="of diverse viruses [64] and subsequently led to an"/>
 <result pre="and subsequently led to an array of serological and molecular" exact="detection" post="techniques. Molecular techniques are comparatively more sensitive and are"/>
 <result pre="utilized not only in a facile form towards the manual" exact="detection" post="of a virus but also as the embedded component"/>
 <result pre="of several viruses. In addition, the traditional techniques for respiratory" exact="virus detection" post="are generally costly, time consuming, labor intensive, and require"/>
 <result pre="several viruses. In addition, the traditional techniques for respiratory virus" exact="detection" post="are generally costly, time consuming, labor intensive, and require"/>
 <result pre="presently focused on pathogenic viruses and are geared up for" exact="detection" post="of viral infections. In this respect, gold (Au) NPs"/>
 <result pre="have become key components in the improvement/advancement of novel nanotechnology-based" exact="detection" post="for several respiratory viruses; Au NPs have been combined"/>
 <result pre="have been combined with silver staining and utilized for the" exact="detection" post="of HPV (human papillomavirus) in a cervical carcinoma cell"/>
 <result pre="and carbon nanotubes, that are being seriously scrutinized for virus" exact="testing" post="and detection [66,67,68]. The advancements in (nano)biohybrid structures are"/>
 <result pre="nanotubes, that are being seriously scrutinized for virus testing and" exact="detection" post="[66,67,68]. The advancements in (nano)biohybrid structures are the common"/>
 <result pre="(nano)biohybrid structures are the common methods for exploiting NPs in" exact="virus detection," post="which can include biomolecules (one or more) derived from"/>
 <result pre="of NP forms which enable rapid, sensitive, direct, and facile" exact="detection" post="with unprecedented multiplexing capabilities. The surface of Au NPs"/>
 <result pre="to a soft ligand, e.g., thiols. The novel Au NP-based" exact="detection" post="approaches have been developed for diverse types of clinically"/>
 <result pre="with a particular focus on the Au NP biohybrid systems," exact="virus detection" post="targets, and assay modalities. Table 3 depicts diverse case"/>
 <result pre="a particular focus on the Au NP biohybrid systems, virus" exact="detection" post="targets, and assay modalities. Table 3 depicts diverse case"/>
 <result pre="several scanometric, electrochemical, fluorometric, or colorimetric systems in Au NP-based" exact="detection" post="of viruses [69]. Detection of SARS-CoV-2: Innovative Nano-Based Discoveries"/>
 <result pre="of viruses [69]. Detection of SARS-CoV-2: Innovative Nano-Based Discoveries The" exact="reverse transcription polymerase chain reaction" post="(RT-PCR) has been generally deployed as a routine diagnosis"/>
 <result pre="[69]. Detection of SARS-CoV-2: Innovative Nano-Based Discoveries The reverse transcription" exact="polymerase chain reaction" post="(RT-PCR) has been generally deployed as a routine diagnosis"/>
 <result pre="chain reaction (RT-PCR) has been generally deployed as a routine" exact="diagnosis" post="method for the detection of CoVs [70]. However, some"/>
 <result pre="been generally deployed as a routine diagnosis method for the" exact="detection" post="of CoVs [70]. However, some false-positive or false-negative reports"/>
 <result pre="plasmonic photothermal (PPT) influence offered a promising substitute for the" exact="diagnosis" post="of COVID-19, clinically. Delicate recognition of the particular arrangements"/>
 <result pre="sensitivity for the examined SARS-CoV-2 sequences with a much lowered" exact="detection" post="limit of 0.22 pM concentration and permitted specific target"/>
 <result pre="plasmonic resonances of PPT, remarkable stability, reliability, and sensitivity in" exact="diagnosis" post="are achievable. The detection of SARS-CoV-2 in medical samples"/>
 <result pre="remarkable stability, reliability, and sensitivity in diagnosis are achievable. The" exact="detection" post="of SARS-CoV-2 in medical samples could be accomplished by"/>
 <result pre="this sensor effectively identified SARS-CoV-2 in culture (with limit of" exact="detection" post="~1.6 Ã— 101 pfu mLâˆ’1) and medical tests (with"/>
 <result pre="Ã— 101 pfu mLâˆ’1) and medical tests (with limit of" exact="detection" post="~2.42 Ã— 102 copies mLâˆ’1). The prepared FET biosensor"/>
 <result pre="copies mLâˆ’1). The prepared FET biosensor showed good sensitivity for" exact="diagnosis" post="of COVID-19 with no sample pretreatment or labeling, but"/>
 <result pre="the protective efficacy of nanocarrier/NPs against viruses that exploit diverse" exact="infection" post="routes are required to be improved and better characterized."/>
 <result pre="may be a promising and effective prophylactic approach against MERS-CoV" exact="infection" post="[87]. In one investigation, by expressing the structural proteins"/>
 <result pre="0.5â€‰Âµg S protein without escape of adjuvant from SARS after" exact="infection" post="with mouse-adapted SARSâ€&quot;CoV; however, eosinophilic infiltrations were detected in"/>
 <result pre="also displayed similarly big inhibition activity (Figure 8) [57]. For" exact="detection" post="of CoVs, some innovative approaches have focused on application"/>
 <result pre="a DNA virus) have been evaluated; GO remarkably inhibited the" exact="infection" post="of these viruses, at non-cytotoxic concentrations, for a 2"/>
 <result pre="and Future Prospects The incorporation of nanoscience for infectious disease" exact="treatment" post="offers novel opportunities to overcome existing challenges of conventional"/>
 <result pre="or specific properties; they have been therefore developed for viral" exact="detection" post="or treatment and are adequately capable of surmounting natural"/>
 <result pre="properties; they have been therefore developed for viral detection or" exact="treatment" post="and are adequately capable of surmounting natural obstructions to"/>
 <result pre="immunodeficiency syndrome (HIV/AIDS), no effective vaccines are presently accessible making" exact="infection" post="detection and treatment a critical necessity. Today, three viruses,"/>
 <result pre="syndrome (HIV/AIDS), no effective vaccines are presently accessible making infection" exact="detection" post="and treatment a critical necessity. Today, three viruses, namely"/>
 <result pre="no effective vaccines are presently accessible making infection detection and" exact="treatment" post="a critical necessity. Today, three viruses, namely MERS- and"/>
 <result pre="facts regarding virulence, pathogenesis, and the real source of viral" exact="infection" post="or mode of transmission still need to be addressed;"/>
 <result pre="Multi-functionalization should be performed for drug delivery platforms, imaging, and" exact="detection" post="systems for viral localization and specific tissue or organ"/>
 <result pre="antioxidants together could serve as an innovative method for the" exact="treatment" post="of acute inflammation with reduced side effects and significant"/>
 <result pre="controlling the pandemic, such as innovative biosensors designed for SARS-CoV-2" exact="detection" post="by applying nano-based technology; the aforementioned biosensor designed by"/>
 <result pre="one health researchInfluenza Pathogenesis and Control-Volume I.SpringerBerlin, Germany2014205218 2.QasimM.LimD.-J.ParkH.NaD.Nanotechnology for" exact="diagnosis" post="and treatment of infectious diseasesJ. Nanosci. Nanotechnol.2014147374738710.1166/jnn.2014.957825942798 3.WejseC.PatscheC.B.KÃ¼hleA.BambaF.J.V.MendesM.S.LemvikG.GomesV.F.RudolfF.Impact of"/>
 <result pre="researchInfluenza Pathogenesis and Control-Volume I.SpringerBerlin, Germany2014205218 2.QasimM.LimD.-J.ParkH.NaD.Nanotechnology for diagnosis and" exact="treatment" post="of infectious diseasesJ. Nanosci. Nanotechnol.2014147374738710.1166/jnn.2014.957825942798 3.WejseC.PatscheC.B.KÃ¼hleA.BambaF.J.V.MendesM.S.LemvikG.GomesV.F.RudolfF.Impact of HIV-1, HIV-2,"/>
 <result pre="Nanosci. Nanotechnol.2014147374738710.1166/jnn.2014.957825942798 3.WejseC.PatscheC.B.KÃ¼hleA.BambaF.J.V.MendesM.S.LemvikG.GomesV.F.RudolfF.Impact of HIV-1, HIV-2, and HIV-1+ 2 dual" exact="infection" post="on the outcome of tuberculosisInt. J. Infect. Dis.20153212813410.1016/j.ijid.2014.12.01525499041 4.BradenC.R.DowellS.F.JerniganD.B.HughesJ.M.Progress"/>
 <result pre="coronavirus infections with particular reference to SARSJ. Antimicrob. Chemother.20086243744110.1093/jac/dkn24318565970 11.PrincipiN.PirallaA.ZampieroA.BianchiniS.UmbrelloG.ScalaA.BosisS.FossaliE.BaldantiF.EspositoS.Bocavirus" exact="infection" post="in otherwise healthy children with respiratory diseasePLoS ONE20151010.1371/journal.pone.0135640 12.GorbalenyaA.E.BakerS.C.BaricR.S.de"/>
 <result pre="Infect. Dis.201818e295e31110.1016/S1473-3099(18)30292-529914800 15.LuM.-P.MaL.-Y.ZhengQ.DongL.-L.ChenZ.-M.Clinical characteristics of adenovirus associated lower respiratory tract" exact="infection" post="in childrenWorld J. Pediatrics2013934634910.1007/s12519-013-0431-324235068 16.MunsterV.J.KoopmansM.van DoremalenN.van RielD.de WitE.A novel"/>
 <result pre="protease mutants from inclusion bodiesProtein Expr. Purif.2016122909610.1016/j.pep.2016.02.01326917227 21.ParboosingR.MaguireG.E.M.GovenderP.KrugerH.G.Nanotechnology and the" exact="treatment" post="of HIV infectionViruses2012448852010.3390/v404048822590683 22.NasrollahzadehM.SajadiS.M.SajjadiM.IssaabadiZ.An Introduction to NanotechnologyInterface Science and"/>
 <result pre="Med.2015111387139710.1016/j.nano.2015.03.009 42.DonalisioM.LeoneF.CivraA.SpagnoloR.OzerO.LemboD.CavalliR.Acyclovir-loaded chitosan nanospheres from nano-emulsion templating for the topical" exact="treatment" post="of herpesviruses infectionsPharmaceutics2018104610.3390/pharmaceutics10020046 43.LausterD.GlanzM.BarduaM.LudwigK.HellmundM.HoffmannU.HamannA.BÃ¶ttcherC.HaagR.HackenbergerC.P.R.Multivalent Peptideâ€&quot;Nanoparticle Conjugates for Influenza-Virus InhibitionAngew."/>
 <result pre="zirconium quantum dots: A new class of nanocrystals for optical" exact="detection" post="of coronavirusHeliyon20184e0076610.1016/j.heliyon.2018.e0076630186985 54.MoY.FisherD.Review of Treatment Modalities Of Middle Repsiratorey"/>
 <result pre="with mucosal influenza virus hemagglutinin vaccine protects against influenza virus" exact="infection" post="in miceVaccine2009275896590510.1016/j.vaccine.2009.07.03719647814 99.BrightR.A.CarterD.M.DanilukS.ToapantaF.R.AhmadA.GavrilovV.MassareM.PushkoP.MytleN.RoweT.Influenza virus-like particles elicit broader immune responses"/>
 <result pre="Res.20151122010.1186/s12917-015-0481-y26293453 106.McGillJ.L.KellyS.M.KumarP.SpeckhartS.HaughneyS.L.HenningsonJ.NarasimhanB.SaccoR.E.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus" exact="infection" post="in the neonatal calfSci. Rep.2018811510.1038/s41598-018-21292-229311619 107.FrancicaJ.R.LynnG.M.LagaR.JoyceM.G.RuckwardtT.J.MorabitoK.M.ChenM.ChaudhuriR.ZhangB.SastryM.Thermoresponsive polymer nanoparticles co-deliver"/>
 <result pre="Biotechnol.201930617718410.1016/j.jbiotec.2019.10.00731614169 127.Sanchez-GuzmanD.Le GuenP.VilleretB.SolaN.Le BorgneR.GuyardA.KemmelA.CrestaniB.SallenaveJ.M.Garcia-VerdugoI.Silver nanoparticle-adjuvanted vaccine protects against lethal influenza" exact="infection" post="through inducing BALT and IgA-mediated mucosal immunityBiomaterials201921711930810.1016/j.biomaterials.2019.11930831279103 128.YeS.ShaoK.LiZ.GuoN.ZuoY.LiQ.LuZ.ChenL.HeQ.HanH.Antiviral Activity"/>
 <result pre="based drug delivery systemAquaculture201951273437710.1016/j.aquaculture.2019.734377 149.SinghL.KrugerH.G.MaguireG.E.M.GovenderT.ParboosingR.The role of nanotechnology in the" exact="treatment" post="of viral infectionsAdv. Infect. Dis.2017410513110.1177/204993611771359328748089 150.DormontF.BrusiniR.CailleauC.ReynaudF.PeramoA.GendronA.MouginJ.GaudinF.VarnaM.CouvreurP.Squalene-based multidrug nanoparticles for"/>
 <result pre="transistor (FET) sensor and its related operational process for the" exact="diagnosis" post="of COVID-19. Reproduced (adapted) with permission from [71]. Copyright"/>
 <result pre="1Table 1 Summary of developed nanoparticulate drug delivery systems towards" exact="treatment" post="and/or therapy of viral infections. Nanoplatform Properties (Shape/Size/Toxicity) Drug"/>
 <result pre="gold NPs-quantum dot (QD) nanocomposites CoVs Chiral plasmonâ€&quot;exciton systems Viral" exact="detection" post="[47] Graphene oxide (GO) sheets Feline CoVs Organism models:"/>
 <result pre="a fixed concentration of added antibody to the sample Viral" exact="detection" post="[49] Gold NPâ€&quot;adjuvanted S protein SARS-CoVs Stimulates significant antigenâ€&quot;specific"/>
 <result pre="protein SARS-CoVs Stimulates significant antigenâ€&quot;specific IgG response against SARSâ€&quot;related CoV" exact="infection" post="Development of vaccines against severe pneumoniaâ€&quot;associated CoVs [50] Cationic"/>
 <result pre="nanoclusters (NCs) PEDV as a model of CoV Ag2S NCs" exact="treatment" post="prohibited the formation of viral negative-strand RNA and viral"/>
 <result pre="QDs CoVs The fluorescence properties of immuno-conjugated QD-magneto-plasmonic NPs Viral" exact="detection" post="[53] nanomaterials-10-01072-t003_Table 3Table 3 Some important Au NP-based strategies"/>
 <result pre="nanomaterials-10-01072-t003_Table 3Table 3 Some important Au NP-based strategies towards the" exact="detection" post="of viruses [69]. Virus Target Au NP Systems Assay"/>
 <result pre="(HA) Influenza Intranasal [98] VLPs NV Capsid protein Norwalk virus" exact="infection" post="Oral [88] VLPs HBV Nucleocapsid protein Hepatitis Intravenous [89]"/>
</results>
